Table 4.
Sleep disturbance × e4 carrier(unadjusted) |
Sleep disturbance × e4 carrier adjusteda with demographics |
Sleep disturbance × e4 carrier adjustedb with demographics and AD medication use |
|
---|---|---|---|
Hazard ratio (95% Cl) | Hazard ratio (95% Cl) | Hazard ratio (95% Cl) | |
Sleep disturbance × e4 carrier |
3.02 [1.77,5.13]*** | 4.83 [2.90, 8.03]*** | 4.38 [2.54, 7.55]*** |
Use of sleep medication (general) |
3.57 [1.26, 10.1]** | 4.61 [1.76, 12.1]*** | 2.40 [0.49, 11.7] |
Did not use sleep medication |
2.80 [1.51, 5.20]*** | 4.80 [2.58, 8.92]*** | 4.70 [2.50, 8.85]*** |
Trazodone use | 1.64 [0.41, 6.65] | 1.64 [0.60,4.46] | 0.79 [0.15,4.11] |
No trazodone use | 3.10 [1.75, 5.50]*** | 5.11 [2.88,9.05]*** | 5.03 [2.81,9.03]*** |
Zolpidem use | 6.43 [1.39,29.7]** | 7.82 [1.56, 39.1]** | 12.0 [2.28,63.4]*** |
No zolpidem use | 2.81 [1.59,4.95]*** | 4.54 [2.64, 7.78]*** | 4.16 [2.34,7.39]*** |
Note. AD = Alzheimer’s disease; CI = confidence interval.
Adjusted for sex, age, education, race, and Hispanic origin.
Adjusted for sex, age, education, race, Hispanic origin, and AD medication use. *p < .1.
p < .05.
p < .01.